Physicians at Atlanta-based Emory University have treated the first patients in an investigational device exemption trial evaluating a Simpsons Interventions device for coronary chronic total occlusions.
The Acolyte Image-Guided Crossing and Re-Entry Catheter System is designed to allow real-time visualization of the blockage and precise guidewire placement in a single device, potentially improving efficiency and predictability in treating CTOs, according to an Aug. 14 news release from the company. The first procedures were performed at Emory University Hospital in Atlanta by Bill Nicholson, MD, and Wissam Jaber, MD.
CTOs occur in up to 20% of coronary artery disease patients, according to a study published in JACC: Cardiovascular Interventions; they are often challenging to treat with percutaneous coronary intervention. The Acolyte system is designed to expand minimally invasive treatment options for these complex lesions.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.